Southpoint Capital Advisors LP

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 27% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Southpoint Capital Advisors LP's trades of Fennec Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
146.72
Quantity 63,891 +0.5%
Value US$3,986,746
Transaction date
Sale
Price
296.60
Quantity 84,844 +39.2%
Value US$1,984,330
Transaction date
Sale
Price
481.34
Quantity 25,421 -15.6%
Value US$3,005,866
Transaction date
Sale
Price
8.00
Quantity 160,100 -4.0%
Value US$1,280,432
Transaction date
Sale
Price
9.35
Quantity 20,609 -0.5%
Value US$192,614
Transaction date
Sale
Price
9.47
Quantity 19,605 -0.5%
Value US$185,663
Transaction date
Sale
Price
9.59
Quantity 26,900 -0.7%
Value US$257,893
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-24 2025-12-24
S Sale
63,891 +0.5%
146.72
US$3,986,746 		63,891 +0.5% 146.72 US$3,986,746
2025-12-24 2025-11-18
S Sale
84,844 +39.2%
296.60
US$1,984,330 		84,844 +39.2% 296.60 US$1,984,330
2025-11-18 2025-11-17
S Sale
25,421 -15.6%
481.34
US$3,005,866 		25,421 -15.6% 481.34 US$3,005,866
2025-11-18 2025-11-14
S Sale
160,100 -4.0%
8.00
US$1,280,432 		160,100 -4.0% 8.00 US$1,280,432
2025-10-10 2025-10-09
S Sale
20,609 -0.5%
9.35
US$192,614 		20,609 -0.5% 9.35 US$192,614
2025-10-10 2025-10-08
S Sale
19,605 -0.5%
9.47
US$185,663 		19,605 -0.5% 9.47 US$185,663
2025-10-10 2025-10-07
S Sale
26,900 -0.7%
9.59
US$257,893 		26,900 -0.7% 9.59 US$257,893